• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Evaluation of Flibanserin: Science and Advocacy at the FDA.

作者信息

Gellad Walid F, Flynn Kathryn E, Alexander G Caleb

机构信息

Division of General Internal Medicine and Center for Pharmaceutical Policy and Prescribing, University of Pittsburgh, Pittsburgh, Pennsylvania2Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania.

Department of Medicine and Center for Patient Care and Outcomes Research, Medical College of Wisconsin, Milwaukee.

出版信息

JAMA. 2015 Sep 1;314(9):869-70. doi: 10.1001/jama.2015.8405.

DOI:10.1001/jama.2015.8405
PMID:26148201
Abstract
摘要

相似文献

1
Evaluation of Flibanserin: Science and Advocacy at the FDA.氟班色林的评估：美国食品药品监督管理局的科学与宣传
JAMA. 2015 Sep 1;314(9):869-70. doi: 10.1001/jama.2015.8405.
2
FDA Approval of Flibanserin--Treating Hypoactive Sexual Desire Disorder.氟立班丝氨获美国食品药品监督管理局批准——用于治疗女性性欲减退症
N Engl J Med. 2016 Jan 14;374(2):101-4. doi: 10.1056/NEJMp1513686. Epub 2015 Dec 9.
3
Flibanserin and Female Sexual Desire.氟立班丝氨与女性性欲
Nurs Womens Health. 2016 Jun-Jul;20(3):309-14. doi: 10.1016/j.nwh.2016.03.002.
4
U.S. Food and Drug Administration Approval of Addyi (Flibanserin) for Treatment of Hypoactive Sexual Desire Disorder.
Eur Urol. 2016 Feb;69(2):379-80. doi: 10.1016/j.eururo.2015.09.050. Epub 2015 Oct 9.
5
Flibanserin and its discontents.氟班色林及其争议
Arch Womens Ment Health. 2017 Apr;20(2):243-247. doi: 10.1007/s00737-016-0693-6. Epub 2016 Nov 17.
6
Margaret McCartney: Flibanserin for low sexual desire is not feminism.
BMJ. 2015 Oct 26;351:h5650. doi: 10.1136/bmj.h5650.
7
FDA advisers to assess drug for low sexual desire in women.
BMJ. 2010 May 25;340:c2786. doi: 10.1136/bmj.c2786.
8
A 'magic bullet' for a lackluster libido? The newly approved Addyi is not yet ready for prime-time women.
Health After 50 Sci Am Consum Health. 2015 Dec;27(12):1-2.
9
US Food and Drug Administration Approval of Flibanserin: Even the Score Does Not Add Up.美国食品药品监督管理局对氟班色林的批准：即便分数加起来也不合理。
JAMA Intern Med. 2016 Apr;176(4):439-42. doi: 10.1001/jamainternmed.2016.0073.
10
US drug agency approves drug for low sexual desire in women.
BMJ. 2015 Aug 20;351:h4522. doi: 10.1136/bmj.h4522.

引用本文的文献

1
Modeling Human Sexual Motivation in Rodents: Some Caveats.在啮齿动物中模拟人类性动机：一些注意事项。
Front Behav Neurosci. 2019 Aug 27;13:187. doi: 10.3389/fnbeh.2019.00187. eCollection 2019.
2
Exposing drug industry funding of UK patient organisations.揭露英国患者组织的药品行业资助情况。
BMJ. 2019 May 22;365:l1806. doi: 10.1136/bmj.l1806.
3
Female sexual dysfunction: a focus on flibanserin.女性性功能障碍：聚焦于氟班色林。
Int J Womens Health. 2017 Oct 11;9:757-767. doi: 10.2147/IJWH.S83747. eCollection 2017.
4
Maximizing the Post-Approval Safety of Flibanserin: A Role for Regulators, Clinicians, and Patients.最大化氟班色林批准后的安全性：监管机构、临床医生和患者的作用
Drug Saf. 2016 May;39(5):375-80. doi: 10.1007/s40264-015-0389-2.
5
Flibanserin: Approval of a controversial drug for a controversial disorder.氟立班丝氨：一种用于治疗一种有争议病症的有争议药物的获批。
Indian J Psychiatry. 2015 Jul-Sep;57(3):221-3. doi: 10.4103/0019-5545.166630.